Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.

Literature DB >> 6427483

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.

Abstract

In a prospective controlled study the influence of long-term mitomycin C instillation therapy on tumor recurrence, progression and patient survival after transurethral resection of superficial bladder tumors was evaluated. This report is an update of a randomized controlled study that was stopped 1.5 years ago. The results show that long-term mitomycin C instillation therapy improves recurrence rate, progression rate and survival in patients with superficial bladder cancer.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1984 PMID： 6427483 DOI： 10.1016/s0022-5347(17)49449-3

Source DB: PubMed Journal: J Urol ISSN： 0022-5347 Impact factor: 7.450

Keyword Cloud
Cited

12 in total

1. Biomarkers for early detection and optimized treatment for transitional cell carcinoma.

Authors: S J Freedland; M H Bui; D Chao; A J Pantuck; A Zisman; A S Belldegrun
Journal: Rev Urol Date: 2001

2. Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA.

Authors: S S Zhu; Y C Zhang; R Z Hu; Z Q Ye; C J Li; Q A Lin
Journal: J Tongji Med Univ Date: 1990

Review 3. Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Authors: M S Highley; A T van Oosterom; R A Maes; E A De Bruijn
Journal: Clin Pharmacokinet Date: 1999-07 Impact factor: 6.447

Review 4. Invasive bladder cancer--possible future treatment considerations.

Authors: R A Gardiner
Journal: Urol Res Date: 1986

5. Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.

Authors: L T Balemans; P D Vegt; P A Steerenberg; E C De Boer; A Van Swaaij; R E De Vries; A P Van der Meijden; W Den Otter
Journal: Urol Res Date: 1994

6. Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study.

Authors: Chang Wook Jeong; Hwang Gyun Jeon; Cheol Kwak; Hyeon Jeong; Sang Eun Lee
Journal: Cancer Res Treat Date: 2005-02-28 Impact factor: 4.679

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival.

1. Biomarkers for early detection and optimized treatment for transitional cell carcinoma.

2. Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA.

Review 3. Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Review 4. Invasive bladder cancer--possible future treatment considerations.

5. Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder.

6. Comparison of 30 mg and 40 mg of mitomycin C intravesical instillation in Korean superficial bladder cancer patients: prospective, randomized study.

7. Intravesical idarubicin--a phase-I study.

8. Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview.

9. Methodologies for quantifying the results of intravesical chemotherapy of superficial tumors of the bladder.

10. CD10 expression in urothelial carcinoma of the bladder.